celecoxib and betadex
celecoxib has been researched along with betadex in 14 studies
Research
Studies (14)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (64.29) | 29.6817 |
| 2010's | 4 (28.57) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Jain, SK; Rawat, S | 1 |
| Chowdhary, KP; Diwan, PV; Ramakrishna, S; Reddy, MN; Rehana, T | 1 |
| Anitha, R; Ghosh, S; Kumria, R; Nanda, A; Sinha, VR | 1 |
| Joshi, MS; Nagarsenker, MS | 1 |
| Corsaro, A; Giannone, I; Paolino, D; Pistarà, V; Puglisi, G; Ventura, CA | 1 |
| Falcone, A; Giannone, I; Mondello, MR; Paolino, D; Puglisi, G; Sdrafkakis, V; Tommasini, S; Ventura, CA | 1 |
| Chowdary, KP; Srinivas, SV | 1 |
| Bhola, M; Gupta, Y; Jain, A; Jain, SK | 1 |
| Anitha, R; Bhinge, JR; Ghosh, S; Kumar, M; Kumria, R; Sinha, VR | 1 |
| Cirri, M; Furlanetto, S; Mennini, N; Mura, P | 1 |
| Cutrignelli, A; Denora, N; Depalo, N; Fanizza, E; Franco, M; Iacobazzi, RM; Laquintana, V; Lopalco, A; Lopedota, A; Mastrodonato, M; Mentino, D; Perrone, M | 1 |
| Cho, KH; Jang, DJ; Jee, JP; Kang, D; Kim, DY; Kim, K; Kim, ST; Kim, YH; Park, SY; Sim, T | 1 |
| Avola, R; Cardile, V; Eleonora Graziano, AC; Pistarà, V; Rescifina, A; Stancanelli, R; Surdo, E; Tommasini, S; Ventura, CA | 1 |
| Ahmad, R; Akhtar, M; Batool, A; Khan, SU; Maqbool, I; Noreen, S; Sadaquat, H | 1 |
Other Studies
14 other study(ies) available for celecoxib and betadex
| Article | Year |
|---|---|
Solubility enhancement of celecoxib using beta-cyclodextrin inclusion complexes.
Topics: beta-Cyclodextrins; Celecoxib; Cyclodextrins; Pyrazoles; Solubility; Sulfonamides | 2004 |
Beta-cyclodextrin complexes of celecoxib: molecular-modeling, characterization, and dissolution studies.
Topics: Anti-Inflammatory Agents, Non-Steroidal; beta-Cyclodextrins; Calorimetry, Differential Scanning; Celecoxib; Cyclodextrins; Microscopy, Electron, Scanning; Models, Molecular; Powders; Protein Conformation; Pyrazoles; Solubility; Sulfonamides; X-Ray Diffraction | 2004 |
Complexation of celecoxib with beta-cyclodextrin: characterization of the interaction in solution and in solid state.
Topics: beta-Cyclodextrins; Calorimetry, Differential Scanning; Celecoxib; Pharmaceutical Solutions; Pyrazoles; Solubility; Sulfonamides | 2005 |
Celecoxib-cyclodextrin systems: characterization and evaluation of in vitro and in vivo advantage.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Administration, Oral; Animals; beta-Cyclodextrins; Calorimetry, Differential Scanning; Celecoxib; Chemistry, Pharmaceutical; Cyclooxygenase Inhibitors; Excipients; Pyrazoles; Rats; Rats, Wistar; Solubility; Sulfonamides; Tablets | 2005 |
Preparation of celecoxib-dimethyl-beta-cyclodextrin inclusion complex: characterization and in vitro permeation study.
Topics: beta-Cyclodextrins; Caco-2 Cells; Celecoxib; Cell Membrane Permeability; Drug Carriers; Humans; Magnetic Resonance Spectroscopy; Pyrazoles; Solubility; Sulfonamides; Thermodynamics | 2005 |
Influence of modified cyclodextrins on solubility and percutaneous absorption of celecoxib through human skin.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Adult; Anti-Inflammatory Agents, Non-Steroidal; beta-Cyclodextrins; Calorimetry, Differential Scanning; Celecoxib; Chromatography, High Pressure Liquid; Circular Dichroism; Female; Humans; In Vitro Techniques; Magnetic Resonance Spectroscopy; Permeability; Pyrazoles; Skin; Skin Absorption; Solubility; Sulfonamides | 2006 |
Influence of hydrophilic polymers on celecoxib complexation with hydroxypropyl beta-cyclodextrin.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Anti-Inflammatory Agents, Non-Steroidal; beta-Cyclodextrins; Calorimetry, Differential Scanning; Celecoxib; Chemistry, Pharmaceutical; Hypromellose Derivatives; Methylcellulose; Polymers; Povidone; Pyrazoles; Solubility; Sulfonamides; X-Ray Diffraction | 2006 |
Multivesicular liposomes bearing celecoxib-beta-cyclodextrin complex for transdermal delivery.
Topics: Administration, Cutaneous; Animals; beta-Cyclodextrins; Carrageenan; Celecoxib; Chemistry, Pharmaceutical; Cyclooxygenase 2 Inhibitors; Delayed-Action Preparations; Drug Compounding; Drug Delivery Systems; Edema; Female; In Vitro Techniques; Liposomes; Male; Particle Size; Permeability; Pyrazoles; Rats; Skin Absorption; Solubility; Sulfonamides | 2007 |
Physicochemical characterization and in vitro dissolution behaviour of celecoxib-beta-cyclodextrin inclusion complexes.
Topics: beta-Cyclodextrins; Calorimetry, Differential Scanning; Celecoxib; Cyclooxygenase 2 Inhibitors; Magnetic Resonance Spectroscopy; Microscopy, Electron, Scanning; Pyrazoles; Solubility; Spectrophotometry, Infrared; Sulfonamides; X-Ray Diffraction | 2007 |
Quality by design approach for developing chitosan-Ca-alginate microspheres for colon delivery of celecoxib-hydroxypropyl-β-cyclodextrin-PVP complex.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; Alginates; beta-Cyclodextrins; Calcium; Celecoxib; Chemistry, Pharmaceutical; Chitosan; Colon; Drug Delivery Systems; Glucuronic Acid; Hexuronic Acids; Microspheres; Particle Size; Polymers; Povidone; Pyrazoles; Solubility; Sulfonamides | 2012 |
Spray Dried Chitosan Microparticles for Intravesical Delivery of Celecoxib: Preparation and Characterization.
Topics: Administration, Intravesical; Animals; beta-Cyclodextrins; Celecoxib; Chemistry, Pharmaceutical; Chitosan; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Freeze Drying; Microspheres; Mucous Membrane; Particle Size; Solubility; Swine; Urinary Bladder; Viscosity | 2016 |
Removing Control of Cyclodextrin-Drug Complexes Using High Affinity Molecule.
Topics: 2-Hydroxypropyl-beta-cyclodextrin; beta-Cyclodextrins; Calorimetry, Differential Scanning; Celecoxib; Cyclodextrins; Cyclooxygenase 2 Inhibitors; Drug Delivery Systems; Hydrophobic and Hydrophilic Interactions; Nanotechnology; Solubility; Spectroscopy, Fourier Transform Infrared | 2018 |
Gemcitabine anticancer activity enhancement by water soluble celecoxib/sulfobutyl ether-β-cyclodextrin inclusion complex.
Topics: A549 Cells; Antineoplastic Agents; beta-Cyclodextrins; Celecoxib; Deoxycytidine; Drug Compounding; Drug Synergism; Gemcitabine; Humans; Molecular Dynamics Simulation; Powders; Solubility; Water | 2019 |
Novel multiparticulate pH triggered delayed release chronotherapeutic drug delivery of celecoxib-β-cyclodextrin inclusion complexes by using Box-Behnken design.
Topics: beta-Cyclodextrins; Calorimetry, Differential Scanning; Celecoxib; Cyclooxygenase 2 Inhibitors; Delayed-Action Preparations; Drug Chronotherapy; Humans; Hydrogen-Ion Concentration; Medication Adherence; Microscopy, Electron, Scanning; Quality of Life; Solubility; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction | 2020 |